Ado-trastuzumab emtansine Intravenous and Tapentadol Extended-Release Tablets
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Tapentadol Hydrochloride
- Ado-trastuzumab emtansine Intravenous-Tapentadol Tablets
- Ado-trastuzumab emtansine Intravenous-TaperDex 12-day
- Ado-trastuzumab emtansine Intravenous-TaperDex 6-day
- Ado-trastuzumab emtansine Intravenous-TaperDex 7-day
- Ado-trastuzumab emtansine Intravenous-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Adox Pak 2/100
- Tapentadol Extended-Release Tablets-Adoxa
- Tapentadol Extended-Release Tablets-Adoxa CK
- Tapentadol Extended-Release Tablets-Adoxa Pak
- Tapentadol Extended-Release Tablets-Adoxa Pak 1/100
- Tapentadol Extended-Release Tablets-Adoxa Pak 1/150